Clinical Trials
44 trialsAtezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
University of Florida
LUPARPED
Fundación de investigación HM
Cabozantinib and Lanreotide as Treatment for Gastroenteropancreatic Neuroendocrine Tumors
National Health Research Institutes, Taiwan
GoTHAM
Melanoma and Skin Cancer Trials Limited
Empirical Radioactive Iodine Therapy in DTC
Assiut University
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies
M.D. Anderson Cancer Center
WB2020
Colorado State University
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
National Health Research Institutes, Taiwan
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
61Cu-NODAGA-LM3 PET/CT for the Detection of Neuroendocrine Tumors (COPPER PET in NET)
University Hospital, Basel, Switzerland
A Study to Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use
AHS Cancer Control Alberta
FETONET
Imperial College London
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine Tumors
Peking Union Medical College Hospital
18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies
Memorial Sloan Kettering Cancer Center
LuX
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
RADNET
Uppsala University
An Open, Single-center Clinical Study of Surufatinib Combined With Temozolomide and S-1 in the First-line Treatment of Advanced Neuroendocrine Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
SPORE-3
University of Iowa
A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer
Dana-Farber Cancer Institute
68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours
Medical University Innsbruck
PLANET
Duke University
REGOMUNE
Institut Bergonié
A Single-arm, Open-label, Clinical Trial of Surufatinib/Serplulimab/Platinum/Etoposide in Neuroendocrine Carcinoma.
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
EBRT
Sunnybrook Health Sciences Centre
PET
Peking Union Medical College Hospital
GA-68
University of Iowa
GLP-1-AHH
Radboud University Medical Center
Dosimetry Guided PRRT With 177Lu-DOTATATE in Children and Adolescents
University of Iowa
DEBOXA for Inoperable NET Liver Metastases
Xiangya Hospital of Central South University
NET-001
Sunnybrook Health Sciences Centre
DOTA-TOC
University of California, San Francisco
Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas
University of Maryland, Baltimore
[18]F-FAZA PET Imaging Study in Patients With Cancer of the Head & Neck, Lung, Renal Cell, Brain, Lymphoma and Neuroendocrine Tumours
AHS Cancer Control Alberta
Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue
King Faisal Specialist Hospital & Research Center
A Study of 18F-AlF-NOTA-octreotide PET/CT for Imaging Neuroendocrine Neoplasms
Xiangya Hospital of Central South University
TODAY!
Northwestern University
GaIN
Insel Gruppe AG, University Hospital Bern
A Phase I/II Study of the Use of Intensity Modulated Radiotherapy (IMRT) in Cancer of the Thyroid, Larynx and Hypopharynx
Royal Marsden NHS Foundation Trust
68Ga-DOTATATE PET Scan Imaging in Patients With Neuroendocrine Tumors
Ochsner Health System
Effect of Carum Carvi on Thyroid Hormones and TSH Level
Mashhad University of Medical Sciences
Hyaluronic Acid Injection Post Arthroscopy - Does it Improve Immediate Function? Double Blind Controlled Prospective Study
Hadassah Medical Organization
Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
University of Wuerzburg
Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor
Guangdong Provincial People's Hospital
Induction Chemotherapy Using Doxorubicin and Cisplatin Followed by Combretastatin A4 Phosphate and Radiation Therapy in Treating Patients With Newly Diagnosed Regionally Advanced Anaplastic Thyroid Cancer
Case Comprehensive Cancer Center